Home › Ewing Sarcoma › Minnesota
Ewing Sarcoma clinical trials in Minnesota
5 studies for Ewing Sarcoma are looking for participants at sites in Minnesota.
Cities in Minnesota
Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)
- Mayo Clinic Childrens Center, Rochester
RecruitingPhase 1
Ages 2 and older · All sexes · Updated Sep 25, 2026 · NCT07297979Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- University of Minnesota/Masonic Cancer Center, Minneapolis
RecruitingPhase 1/2
12 Months – 30 Years · All sexes · Updated Aug 25, 2026 · NCT04851119Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma
- University of Minnesota, Minneapolis
Recruiting
Up to age 39 · All sexes · Updated Jul 13, 2026 · NCT06796543Biologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR Trial
- Mayo Clinic in Rochester, Rochester
Recruiting
Ages 2 and older · All sexes · Updated Jun 4, 2026 · NCT07188532Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Children's Hospital and Clinics of Minn, Minneapolis
RecruitingPhase 1/2
12 Months – 30 Years · All sexes · Updated May 19, 2026 · NCT04901702From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.